Management of advanced head and neck cancer with intertissue injection of 32P radioisotope
- VernacularTitle:胶体组织间注射治疗晚期头颈部鳞状细胞癌的临床观察
- Author:
Yanchen WANG
;
Hong ZHANG
;
Baoliang YANG
;
Shigeng PEI
;
Xueling WANG
;
Xiaohui DUAN
- Publication Type:Journal Article
- Keywords:
Phosphorus Radioisotope;
Radiotherapy,Computer-Assisted;
Head and Neck Neoplasms;
Carcinoma,Squamous Cell
- From:
Chinese Archives of Otolaryngology-Head and Neck Surgery
2006;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To observe the effect of 32P intertissue injection on advanced head and neck cancer. METHODS Eight patients with advanced head and neck cancer were treated with 32P injection into the tumors according to the size of the cancer as determined by CT scan. RESULTS Local tumors were controlled evidently and the pain of the patients were alleviated. The survival periods of the 8 cases ranged from 3 to 18 months (average 14.2 months). CONCLUSION 32P intertissue injection offer an useful method for patients with advanced head and neck cancer .
